Marshall Wace North America’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Marshall Wace North America's MRK Position: Q3 2021 in Review
Marshall Wace North America reduced its Merck (MRK) stake by 64% in Q3 2021, selling an estimated $12.1M and leaving 88,135 shares worth $6.62M. The position accounts for 0.03% of the portfolio, ranked #439.
Marshall Wace North America first reported a position in MRK in Q2 2013 and has held it in 21 quarters since. The position peaked at $253M in Q2 2019. 2,648 funds tracked by Wall St. Rank hold MRK as of Q3 2021.
- Marshall Wace North America held 88,135 shares of Merck worth $6.62M as of Q3 2021.
- Marshall Wace North America sold 158,970 Merck shares in Q3 2021, an estimated $12.1M.
- Merck made up 0.03% of Marshall Wace North America's portfolio in Q3 2021, its #439 holding.
- Marshall Wace North America first reported a position in Merck in Q2 2013 and has held it in 21 quarters since.
- Marshall Wace North America's Merck position peaked at $253M in Q2 2019.
- 2,648 funds tracked by Wall St. Rank held Merck as of Q3 2021.
Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.